OverviewSuggest Edit

EDAP TMS currently develops and markets high-technology medical devices for the treatment of certain types of urological disorders including the ablation of localized prostate cancer tumors using HIFU (High Intensity Focused Ultrasound) technology and the removal of urinary tract stones using ESWL (Extracorporeal ShockWave Lithotripsy).
TypePublic
Founded1979
HQVaulx-en-Velin, FR
Websiteedap-tms.com

Latest Updates

Employees (est.) (Feb 2019)200
Job Openings1
Revenue (FY, 2017)€35.7 M
Share Price (Oct 2019)$4.6

Key People/Management at EDAP TMS

Marc Oczachowski

Marc Oczachowski

CEO
François Dietsch

François Dietsch

CFO
Show more

EDAP TMS Office Locations

EDAP TMS has an office in Vaulx-en-Velin
Vaulx-en-Velin, FR (HQ)
4 Rue du Dauphiné
Show all (1)

EDAP TMS Financials and Metrics

EDAP TMS Revenue

Embed Graph
View revenue for all periods
EDAP TMS's revenue was reported to be €35.75 m in FY, 2017 which is a 0.4% increase from the previous period.
EUR

Revenue (FY, 2017)

35.7m

Revenue growth (FY, 2016 - FY, 2017), %

0.4%

Gross profit (FY, 2017)

14.8m

Gross profit margin (FY, 2017), %

41.4%

Net income (FY, 2017)

(681.0k)

EBIT (FY, 2017)

(3.2m)

Market capitalization (11-Oct-2019)

134.0m

Closing stock price (11-Oct-2019)

4.6

Cash (31-Dec-2017)

20.0m

EV

117.5m
EDAP TMS's current market capitalization is $134 m.
EURFY, 2015FY, 2016FY, 2017

Revenue

32.3m35.6m35.7m

Revenue growth, %

10%0%

Cost of goods sold

18.5m19.2m20.9m

Gross profit

13.8m16.4m14.8m
EURFY, 2015FY, 2016FY, 2017

Cash

13.6m22.0m20.0m

Accounts Receivable

10.7m9.1m11.3m

Current Assets

33.0m40.5m39.6m

PP&E

2.1m2.8m3.7m
EURFY, 2015FY, 2016FY, 2017

Net Income

(1.7m)(3.8m)(681.0k)

Depreciation and Amortization

1.0m1.0m1.6m

Inventories

(381.0k)(2.0m)669.0k

Accounts Payable

518.0k(153.0k)426.0k
EURY, 2017

EV/EBIT

-36.7 x

EV/CFO

-38.4 x

Revenue/Employee

181.5k

Financial Leverage

1.9 x
Show all financial metrics

EDAP TMS Revenue Breakdown

Embed Graph

EDAP TMS revenue breakdown by business segment: 73.4% from UDS Division and 26.6% from HIFU Division

EDAP TMS revenue breakdown by geographic segment: 30.0% from France, 27.0% from Others geographical areas, 38.0% from Asia and 5.0% from Other

EDAP TMS Online and Social Media Presence

Embed Graph

EDAP TMS News and Updates

EDAP TMS SA : EDAP Reports Q4 and Full Year 2018 Results

Reports record revenues for the fifth consecutive year

EDAP TMS SA : EDAP TMS SA to Announce Fourth Quarter and Fiscal Year 2018 Financial Results on Monday, April 1, 2019

Company to host conference call and webcast on Tuesday, April 2 at 8:30am EDT

EDAP TMS SA : EDAP Announces the Purchase of Focal One® HIFU by Maimonides Medical Center, Brooklyn, NY

Maimonides Medical Center to Become the First Hospital on the East Coast of the US to Acquire Focal One Technology and Offer the World's Most Advanced HIFU Prostate Treatment

EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference

LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference, taking place November 27-29, 2018 in New York City.

EDAP TMS SA : EDAP Reports 2018 Third Quarter Results

LYON, France, November 14, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, announced today financial results for the third quarter and nine-month period of 2018 and provided a strategic and operational update. Management will host a conference call…

EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14

LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September 30, 2018, after the close of the financial markets on Wednesday, November 14, …
Show more

EDAP TMS Blogs

EDAP Reports 2019 Second Quarter Results

Third consecutive profitable quarter Positive reimbursement decision by the American Medical Association announced in June Significant improvement in gross profit margin from 41.3% in Q2 2018 to 50.7% in Q2 2019 Q2 HIFU sales growth of 98% year-over-year Total Q2 revenues of EUR 12.5 million ; +45%

EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019

EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019 Content Import Thu, 07/25/2019 - 08:01 EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019 Jul 25,2019 This release is a backfill from a News Wire …

EDAP TMS SA : EDAP TMS SA to Announce Second Quarter 2018 Financial Results on Thursday, August 30

LYON, France , July 24, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the second quarter and six months ended June 30, 2018 , before the open of the financial markets on Thursday, August 30, 2018 .

EDAP TMS Frequently Asked Questions

  • When was EDAP TMS founded?

    EDAP TMS was founded in 1979.

  • Who are EDAP TMS key executives?

    EDAP TMS's key executives are Marc Oczachowski and François Dietsch.

  • How many employees does EDAP TMS have?

    EDAP TMS has 200 employees.

  • What is EDAP TMS revenue?

    Latest EDAP TMS annual revenue is €35.7 m.

  • What is EDAP TMS revenue per employee?

    Latest EDAP TMS revenue per employee is €178.7 k.

  • Who are EDAP TMS competitors?

    Competitors of EDAP TMS include Biotronik, Abyrx and VytronUS.

  • Where is EDAP TMS headquarters?

    EDAP TMS headquarters is located at 4 Rue du Dauphiné, Vaulx-en-Velin.

  • Where are EDAP TMS offices?

    EDAP TMS has an office in Vaulx-en-Velin.

  • How many offices does EDAP TMS have?

    EDAP TMS has 1 office.